Business
CBR Patent Application Update
CBR Patent Application Update.
About this update from Hemogenyx Pharmaceuticals Plc
[{"type":"text","content":"\n\nReach - non-regulatory\n \n8 September 2023\n \nHemogenyx Pharmaceuticals plc \n(\"Hemogenyx Pharmaceuticals\" or the \"Company\")\n \nCBR Patent Application Update\n \n \nHemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that its patent application number \"WO2023168292 Chimeric Bait Receptors and Uses Thereof\" was published on 7 September 2023 by the World Intellectual Property Organization (\"WIPO\"). It remains to be reviewed and approved by national patent authorities.\n \n \nEnquiries:\n \n\n\n\nHemogenyx Pharmaceuticals plc\n\n\nhttps://hemogenyx.com\n\n\n\n\nDr Vladislav Sandler, Chief Executive Officer & Co-Founder\n\n\[email protected]\n\n\n\n\nPeter Redmond, Director\n\n\[email protected]\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSP Angel Corporate Finance LLP\n\n\nTel: +44 (0)20 3470 0470\n\n\n\n\nMatthew Johnson, Vadim Alexandre, Adam Cowl\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeterhouse Capital Limited\n\n\nTel: +44 (0)20 7469 0930\n\n\n\n\nLucy Williams, Duncan Vasey, Charles Goodfellow\n\n\n\n\n\n\n\n \n \nAbout Hemogenyx Pharmaceuticals plc\nHemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility.\nThe Company is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.\n\n","length":5429,"tagName":"div"}]